<DOC>
	<DOCNO>NCT00513994</DOCNO>
	<brief_summary>The purpose study measure much nitroglycerin metabolite may find bloodstream MQX-503 FDA approve Nitroglycerin ointment 2 % USP apply skin healthy subject .</brief_summary>
	<brief_title>MQX-503 v Nitroglycerin Ointment : A Pharmacokinetic Comparison Normal Subjects</brief_title>
	<detailed_description />
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Healthy volunteer 18 70 year age . Subjects able give write informed consent comply study requirement . Subjects willing able safely discontinue current prescription therapy . Subjects agree participate clinical trial . Negative pregnancy test fertile female agreement use effective contraception throughout study . Persons would put risk discontinue prescription therapy . Subjects know allergy nitroglycerin . Subjects condition issue would adversely affect application study medication , study evaluation subject 's ability comply protocol . Subjects recently experience myocardial infarction , uncontrolled congestive heart failure , unstable angina , uncontrolled hypotension uncontrolled hypertension . Subjects participate study investigational drug within two week visit 1 . Subjects screen lab value range consider clinically significant investigator . Subjects major abdominal , thoracic , vascular surgery within 6 month visit 1 . Subjects nonepithelialized skin lesion interfere skin condition time screen area study medication apply . Pregnant nursing woman . Women childbearing potential unwilling comply contraceptive requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Nitroglycerin</keyword>
	<keyword>pharmacokinetics study nitroglycerin containing treatment</keyword>
</DOC>